A Phase I Clinical Trial of Flavone-8-Acetic Acid in Combination With Interleukin 2
Authors: J. T. Holmlund, W. C. Kopp, R. H. Wiltrout, D. L. Longo, W. J. Urba, J. E. Janik, M. Sznol, K. C. Conlon, R. G. Fenton, R. Hornung, K. Madara, M. A. Shields, J. W. Smith, W. Sharfman, R. G. Steis, C. Ewel, L. Malspeis, S. P. Creekmore
Journal: JNCI Journal of the National Cancer Institute (1995)

Journal Article A Phase I Clinical Trial of Flavone-8-Acetic Acid in Combination With Interleukin 2 Get access Jon T. Holmlund, Jon T. Holmlund Clinical Research Branch, Biological Response Modifiers Program, National Cancer Institute (NCI), NCI-Frederick Cancer Research and Development CenterFrederick, Md Correspondence to: Jon T. Holmlund, M.D., National Cancer Institute-Frederick Cancer Research and Development Center, Bldg. 1052, Rm. 253, Frederick, MD 21702. Search for other works by this author on: Oxford Academic PubMed Google Scholar William C. Kopp, William C. Kopp Clinical Services Program, Program Resources, Inc./Dyn-Corp, NCI-Frederick Cancer Research and Development CenterFrederick Search for other works by this author on: Oxford Academic PubMed Google Scholar Robert H. Wiltrout, Robert H. Wiltrout Clinical Research Branch, Biological Response Modifiers Program, National Cancer Institute (NCI), NCI-Frederick Cancer Research and Development CenterFrederick, Md Search for other works by this author on: Oxford Academic PubMed Google Scholar Dan L. Longo, Dan L. Longo Clinical Research Branch, Biological Response Modifiers Program, National Cancer Institute (NCI), NCI-Frederick Cancer Research and Development CenterFrederick, Md Search for other works by this author on: Oxford Academic PubMed Google Scholar Walter J. Urba, Walter J. Urba Clinical Services Program, Program Resources, Inc./Dyn-Corp, NCI-Frederick Cancer Research and Development CenterFrederick Search for other works by this author on: Oxford Academic PubMed Google Scholar John E. Janik, John E. Janik Clinical Research Branch, Biological Response Modifiers Program, National Cancer Institute (NCI), NCI-Frederick Cancer Research and Development CenterFrederick, Md Search for other works by this author on: Oxford Academic PubMed Google Scholar Mario Sznol, Mario Sznol Clinical Research Branch, Biological Response Modifiers Program, National Cancer Institute (NCI), NCI-Frederick Cancer Research and Development CenterFrederick, Md Search for other works by this author on: Oxford Academic PubMed Google Scholar Kevin C. Conlon, Kevin C. Conlon Clinical Research Branch, Biological Response Modifiers Program, National Cancer Institute (NCI), NCI-Frederick Cancer Research and Development CenterFrederick, Md Search for other works by this author on: Oxford Academic PubMed Google Scholar Robert G. Fenton, Robert G. Fenton Clinical Research Branch, Biological Response Modifiers Program, National Cancer Institute (NCI), NCI-Frederick Cancer Research and Development CenterFrederick, Md Search for other works by this author on: Oxford Academic PubMed Google Scholar Ronald Hornung, Ronald Hornung Clinical Services Program, Program Resources, Inc./Dyn-Corp, NCI-Frederick Cancer Research and Development CenterFrederick Search for other works by this author on: Oxford Academic PubMed Google Scholar ... Show more Karen Madara, Karen Madara Frederick Memorial HospitalWest Seventh Street, Frederick Search for other works by this author on: Oxford Academic PubMed Google Scholar Mary Ann Shields, Mary Ann Shields Frederick Memorial HospitalWest Seventh Street, Frederick Search for other works by this author on: Oxford Academic PubMed Google Scholar John W. Smith, II, John W. Smith, II Clinical Research Branch, Biological Response Modifiers Program, National Cancer Institute (NCI), NCI-Frederick Cancer Research and Development CenterFrederick, Md Search for other works by this author on: Oxford Academic PubMed Google Scholar William Sharfman, William Sharfman Clinical Research Branch, Biological Response Modifiers Program, National Cancer Institute (NCI), NCI-Frederick Cancer Research and Development CenterFrederick, Md Search for other works by this author on: Oxford Academic PubMed Google Scholar Ronald G. Steis, Ronald G. Steis Clinical Research Branch, Biological Response Modifiers Program, National Cancer Institute (NCI), NCI-Frederick Cancer Research and Development CenterFrederick, Md Search for other works by this author on: Oxford Academic PubMed Google Scholar Cynthia Ewel, Cynthia Ewel Clinical Research Branch, Biological Response Modifiers Program, National Cancer Institute (NCI), NCI-Frederick Cancer Research and Development CenterFrederick, Md Search for other works by this author on: Oxford Academic PubMed Google Scholar Louis Malspeis, Louis Malspeis Clinical Research Branch, Biological Response Modifiers Program, National Cancer Institute (NCI), NCI-Frederick Cancer Research and Development CenterFrederick, Md Search for other works by this author on: Oxford Academic PubMed Google Scholar Stephen P. Creekmore Stephen P. Creekmore Clinical Research Branch, Biological Response Modifiers Program, National Cancer Institute (NCI), NCI-Frederick Cancer Research and Development CenterFrederick, Md Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 87, Issue 2, 18 January 1995, Pages 134–136, https://doi.org/10.1093/jnci/87.2.134 Published: 18 January 1995 Article history Received: 13 July 1994 Revision received: 18 October 1994 Accepted: 31 October 1994 Published: 18 January 1995